PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-11.55%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-9.98%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-11.76%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
-0.24%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
-8.40%
R&D reduction while CRWV shows 0.00% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.09%
Operating expenses reduction while CRWV shows 17.97% growth. Joel Greenblatt would examine advantage.
-3.31%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-10.73%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-18.39%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-28.09%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-18.88%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-8.29%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
138.08%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
-3.34%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
9.28%
Pre-tax margin growth below 50% of CRWV's 26.86%. Michael Burry would check for structural issues.
-3.37%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-3.33%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
9.29%
Net margin growth below 50% of CRWV's 25.27%. Michael Burry would check for structural issues.
-5.00%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
1.14%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
0.42%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.